HBV REACTIVATION IN HBSAG NEGATIVE PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES POST CHEMOTHERAPY: CASE REPORTS

被引：0
|
作者：
Graziani, F. [1 ]
Esposito, D. [1 ]
De Falco, G. [1 ]
Caparrotti, G. [1 ]
Iovane, E. [1 ]
Pagnini, D. [1 ]
机构：
[1] ASL CE, San Felice A Cancello, CE, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1001
引用
收藏
页码：399 / 399
页数：1
相关论文
共 50 条
  • [21] RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy
    Ergenc, Ilkay
    Kani, Haluk Tarik
    Karabacak, Murat
    Ozer, Elif Comert
    Mehdiyev, Shahin
    Jafarov, Fuad
    Abacar, Kerem Yigit
    Agackiran, Seda Kutlug
    Sevik, Gizem
    Aslan, Rahmi
    Oner, Fatma Alibaz
    Inanc, Nevsun
    Atagunduz, Mehmet Pamir
    Seckin, Dilek
    Alahdab, Yesim Ozen
    Ergun, Tulin
    Direskeneli, Haner
    Atug, Ozlen
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (03): : 310 - 310
  • [22] Measurement of intrahepatic HBV DNA in HBsAg-negative patients
    Kim, YS
    Jang, JY
    Kim, YS
    Hyang, SC
    Han, CH
    Eun, SH
    Cheon, YK
    Moon, JH
    Cho, YD
    Shim, CS
    Kim, BS
    HEPATOLOGY, 2005, 42 (04) : 721A - 722A
  • [23] Serum HBsAg positive but HBV DNA PCR negative patients
    Esmaeilzadeh, A
    Kalantari, S
    IMMUNOLOGY 2004: IMMUNODEFICIENCY, INFECTIOUS DISEASES, IMMUNOMODULATION, AND VACCINES, 2004, : 55 - 57
  • [24] HBsAg transcomplementation of defective HBV genomes in HBeAg negative chronic HBV infected patients
    Peiffer, K. -H.
    Kuhnhenn, L.
    Jiang, B.
    Vermehren, J.
    Knop, V.
    Zeuzem, S.
    Sarrazin, C.
    Hildt, E.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S775 - S775
  • [25] To study prevalence of occult HBV infection & reactivation of HBV in hematological cancer patients on chemotherapy
    Gireesh, N.
    Venketeshwaran, A. R.
    Solomon, Rajkumar
    Malarvizhi, M.
    Murali, R.
    Chezhian, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 710 - 710
  • [26] A close monitoring of virological and immunological hepatitis B markers can improve the diagnosis of HBV reactivation in HBsAg-negative/anti-HBc-positive patients with oncohematological diseases
    Salpini, R.
    Cerva, C.
    Battisti, A.
    Piermatteo, L.
    Sacco, A.
    Malagnino, V.
    Arcese, W.
    Cantonetti, M.
    Ceccherini-Silberstein, F.
    Perno, C. F.
    Andreoni, M.
    Sarmati, L.
    Svicher, V.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E67 - E67
  • [27] Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy
    Cheung, Wing-I.
    Chan, Henry Lik-Yuen
    Leung, Vincent King-Sun
    Tse, Chi-Hang
    Fung, Kitty
    Lin, Shek-Ying
    Wong, Ann
    Wong, Vincent Wai-Sun
    Chau, Tai-Nin
    JOURNAL OF CLINICAL VIROLOGY, 2010, 47 (02) : 193 - 195
  • [28] HBV reinfection in liver transplant (LT) patients (PTS) who remained HBsAg negative post-LT.
    Ghany, MG
    Ayola, B
    Villamil, FG
    Gish, R
    Rojter, S
    Vierling, JM
    Lok, ASF
    HEPATOLOGY, 1996, 24 (04) : 1165 - 1165
  • [29] Primary prophylaxis with lamivudine of hepatitis B virus (HBV) reactivation in HBsAG-positive patients undergoing chemotherapy for hematologic malignancies.
    Rossi, G
    Pelizzari, A
    Motta, M
    Puoti, M
    BLOOD, 2000, 96 (11) : 23A - 23A
  • [30] Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series
    d'Ettorre, G.
    Barbarini, G.
    Corti, F.
    Gobber, M.
    Pastecchia, C.
    Ricci, G. L.
    Siciliano, M.
    Annicchiarico, B. E.
    Vullo, V.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (06) : 551 - 554
12345